<SEC-DOCUMENT>0001104659-20-061592.txt : 20200514
<SEC-HEADER>0001104659-20-061592.hdr.sgml : 20200514
<ACCEPTANCE-DATETIME>20200514160600
ACCESSION NUMBER:		0001104659-20-061592
CONFORMED SUBMISSION TYPE:	DEFA14A
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20200514
DATE AS OF CHANGE:		20200514
EFFECTIVENESS DATE:		20200514

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			INCYTE CORP
		CENTRAL INDEX KEY:			0000879169
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
		IRS NUMBER:				943136539
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DEFA14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-12400
		FILM NUMBER:		20877736

	BUSINESS ADDRESS:	
		STREET 1:		1801 AUGUSTINE CUT-OFF
		CITY:			WILMINGTON
		STATE:			DE
		ZIP:			19803
		BUSINESS PHONE:		3024986700

	MAIL ADDRESS:	
		STREET 1:		1801 AUGUSTINE CUT-OFF
		CITY:			WILMINGTON
		STATE:			DE
		ZIP:			19803

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	INCYTE CORP
		DATE OF NAME CHANGE:	20030318

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	INCYTE GENOMICS INC
		DATE OF NAME CHANGE:	20000710

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	INCYTE PHARMACEUTICALS INC
		DATE OF NAME CHANGE:	19930902
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEFA14A
<SEQUENCE>1
<FILENAME>a20-5765_7defa14a.htm
<DESCRIPTION>DEFA14A
<TEXT>


<html>
<head>



  </head>
<body link=blue lang="EN-US" style="text-justify-trim:punctuation">
<div>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">UNITED STATES</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">SECURITIES AND EXCHANGE COMMISSION</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Washington, D.C. 20549</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="4" face="Times New Roman" style="font-size:13.0pt;font-weight:bold;">SCHEDULE 14A</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Proxy Statement Pursuant to Section 14(a) of</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">the Securities Exchange Act of 1934 (Amendment No.&#160; &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;)</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div align="center">
<table border="0" cellspacing="0" cellpadding="0" width="99%" style="border-collapse:collapse;width:99.0%;">
<tr style="page-break-inside:avoid;">
<td width="100%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:100.0%;">
<p style="font-size:10.0pt;margin:2.0pt 0in 2.0pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Filed by the Registrant   </font><font face="Wingdings">x</font></p>    </td>   </tr>
<tr style="page-break-inside:avoid;">
<td width="100%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:100.0%;">
<p style="font-size:10.0pt;margin:2.0pt 0in 2.0pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Filed by a Party other   than the Registrant </font><font face="Wingdings">o</font></p>    </td>   </tr>
<tr style="page-break-inside:avoid;">
<td width="100%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:100.0%;">
<p style="margin:2.0pt 0in 2.0pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Check the appropriate   box:</font></p>    </td>   </tr>
<tr style="page-break-inside:avoid;">
<td width="11%" valign="top" style="padding:0in 0in 0in 0in;width:11.36%;">
<p style="margin:2.0pt 0in 2.0pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font></p>    </td>
<td width="88%" valign="top" style="padding:0in 0in 0in 0in;width:88.64%;">
<p style="margin:2.0pt 0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Preliminary   Proxy Statement</font></p>    </td>   </tr>
<tr style="page-break-inside:avoid;">
<td width="11%" valign="top" style="padding:0in 0in 0in 0in;width:11.36%;">
<p style="margin:2.0pt 0in 2.0pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font></p>    </td>
<td width="88%" valign="top" style="padding:0in 0in 0in 0in;width:88.64%;">
<p style="margin:2.0pt 0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Confidential,   for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))</font></b></p>    </td>   </tr>
<tr style="page-break-inside:avoid;">
<td width="11%" valign="top" style="padding:0in 0in 0in 0in;width:11.36%;">
<p style="margin:2.0pt 0in 2.0pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font></p>    </td>
<td width="88%" valign="top" style="padding:0in 0in 0in 0in;width:88.64%;">
<p style="margin:2.0pt 0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Definitive Proxy   Statement</font></p>    </td>   </tr>
<tr style="page-break-inside:avoid;">
<td width="11%" valign="top" style="padding:0in 0in 0in 0in;width:11.36%;">
<p style="margin:2.0pt 0in 2.0pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Wingdings" style="font-size:10.0pt;">x</font></p>    </td>
<td width="88%" valign="top" style="padding:0in 0in 0in 0in;width:88.64%;">
<p style="margin:2.0pt 0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Definitive   Additional Materials</font></p>    </td>   </tr>
<tr style="page-break-inside:avoid;">
<td width="11%" valign="top" style="padding:0in 0in 0in 0in;width:11.36%;">
<p style="margin:2.0pt 0in 2.0pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font></p>    </td>
<td width="88%" valign="top" style="padding:0in 0in 0in 0in;width:88.64%;">
<p style="margin:2.0pt 0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Soliciting   Material under &#167;240.14a-12</font></p>    </td>   </tr>  </table>
</div>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div align="center">
<table border="0" cellspacing="0" cellpadding="0" width="99%" style="border-collapse:collapse;width:99.0%;">
<tr style="page-break-inside:avoid;">
<td width="100%" colspan="3" valign="top" style="padding:0in 0in 0in 0in;width:100.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">INCYTE   CORPORATION</font></b></p>    </td>   </tr>
<tr style="page-break-inside:avoid;">
<td width="100%" colspan="3" valign="top" style="padding:0in 0in 0in 0in;width:100.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;"><br>   (Name of Registrant as Specified In Its Charter)</font></p>    </td>   </tr>
<tr style="page-break-inside:avoid;">
<td width="100%" colspan="3" valign="top" style="padding:0in 0in 0in 0in;width:100.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;"><br>   (Name of Person(s) Filing Proxy Statement, if other than the Registrant)</font></p>    </td>   </tr>
<tr style="page-break-inside:avoid;">
<td width="100%" colspan="3" valign="top" style="padding:0in 0in 0in 0in;width:100.0%;">
<p style="margin:2.0pt 0in 2.0pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Payment of Filing Fee   (Check the appropriate box):</font></p>    </td>   </tr>
<tr style="page-break-inside:avoid;">
<td width="11%" valign="top" style="padding:0in 0in 0in 0in;width:11.36%;">
<p style="margin:2.0pt 0in 2.0pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Wingdings" style="font-size:10.0pt;">x</font></p>    </td>
<td width="88%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:88.64%;">
<p style="margin:2.0pt 0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">No fee required.<br><br></font></p>    </td>   </tr>
<tr style="page-break-inside:avoid;">
<td width="11%" valign="top" style="padding:0in 0in 0in 0in;width:11.36%;">
<p style="margin:2.0pt 0in 2.0pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font></p>    </td>
<td width="88%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:88.64%;">
<p style="margin:2.0pt 0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Fee computed on   table below per Exchange Act Rules 14a-6(i)(1) and 0-11.</font></p>    </td>   </tr>
<tr style="page-break-inside:avoid;">
<td width="11%" valign="top" style="padding:0in 0in 0in 0in;width:11.36%;">
<p style="margin:2.0pt 0in 2.0pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.2%;">
<p style="margin:2.0pt 0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(1)</font></p>    </td>
<td width="82%" valign="top" style="padding:0in 0in 0in 0in;width:82.44%;">    <div style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;">
<p style="border:none;margin:2.0pt 0in;padding:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Title of each class of securities to which   transaction applies: <br><br></font></p>    </div>    </td>   </tr>
<tr style="page-break-inside:avoid;">
<td width="11%" valign="top" style="padding:0in 0in 0in 0in;width:11.36%;">
<p style="margin:2.0pt 0in 2.0pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.2%;">
<p style="margin:2.0pt 0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(2)</font></p>    </td>
<td width="82%" valign="top" style="padding:0in 0in 0in 0in;width:82.44%;">    <div style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;">
<p style="border:none;margin:2.0pt 0in;padding:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Aggregate number of securities to which transaction   applies: <br><br></font></p>    </div>    </td>   </tr>
<tr style="page-break-inside:avoid;">
<td width="11%" valign="top" style="padding:0in 0in 0in 0in;width:11.36%;">
<p style="margin:2.0pt 0in 2.0pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.2%;">
<p style="margin:2.0pt 0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(3)</font></p>    </td>
<td width="82%" valign="top" style="padding:0in 0in 0in 0in;width:82.44%;">    <div style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;">
<p style="border:none;margin:2.0pt 0in;padding:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Per unit price or other underlying value of   transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount   on which the filing fee is calculated and state how it was determined): <br><br></font></p>    </div>    </td>   </tr>
<tr style="page-break-inside:avoid;">
<td width="11%" valign="top" style="padding:0in 0in 0in 0in;width:11.36%;">
<p style="margin:2.0pt 0in 2.0pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.2%;">
<p style="margin:2.0pt 0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(4)</font></p>    </td>
<td width="82%" valign="top" style="padding:0in 0in 0in 0in;width:82.44%;">    <div style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;">
<p style="border:none;margin:2.0pt 0in;padding:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Proposed maximum aggregate value of transaction: <br><br></font></p>    </div>    </td>   </tr>
<tr style="page-break-inside:avoid;">
<td width="11%" valign="top" style="padding:0in 0in 0in 0in;width:11.36%;">
<p style="margin:2.0pt 0in 2.0pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.2%;">
<p style="margin:2.0pt 0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(5)</font></p>    </td>
<td width="82%" valign="top" style="padding:0in 0in 0in 0in;width:82.44%;">    <div style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;">
<p style="border:none;margin:2.0pt 0in;padding:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Total fee paid: <br><br></font></p>    </div>    </td>   </tr>
<tr style="page-break-inside:avoid;">
<td width="11%" valign="top" style="padding:0in 0in 0in 0in;width:11.36%;">
<p style="margin:2.0pt 0in 2.0pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font></p>    </td>
<td width="88%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:88.64%;">
<p style="margin:2.0pt 0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Fee paid   previously with preliminary materials.</font></p>    </td>   </tr>
<tr style="page-break-inside:avoid;">
<td width="11%" valign="top" style="padding:0in 0in 0in 0in;width:11.36%;">
<p style="margin:2.0pt 0in 2.0pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font></p>    </td>
<td width="88%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:88.64%;">
<p style="margin:2.0pt 0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Check box if any   part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and   identify the filing for which the offsetting fee was paid previously.   Identify the previous filing by registration statement number, or the Form or   Schedule and the date of its filing.</font></p>    </td>   </tr>
<tr style="page-break-inside:avoid;">
<td width="11%" valign="top" style="padding:0in 0in 0in 0in;width:11.36%;">
<p style="margin:2.0pt 0in 2.0pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.2%;">
<p style="margin:2.0pt 0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(1)</font></p>    </td>
<td width="82%" valign="top" style="padding:0in 0in 0in 0in;width:82.44%;">    <div style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;">
<p style="border:none;margin:2.0pt 0in;padding:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Amount Previously Paid: <br> &nbsp;&nbsp;&nbsp;&nbsp; </font></p>    </div>    </td>   </tr>
<tr style="page-break-inside:avoid;">
<td width="11%" valign="top" style="padding:0in 0in 0in 0in;width:11.36%;">
<p style="margin:2.0pt 0in 2.0pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.2%;">
<p style="margin:2.0pt 0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(2)</font></p>    </td>
<td width="82%" valign="top" style="padding:0in 0in 0in 0in;width:82.44%;">    <div style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;">
<p style="border:none;margin:2.0pt 0in;padding:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Form, Schedule or Registration Statement No.: <br> &nbsp;&nbsp;&nbsp;&nbsp; </font></p>    </div>    </td>   </tr>
<tr style="page-break-inside:avoid;">
<td width="11%" valign="top" style="padding:0in 0in 0in 0in;width:11.36%;">
<p style="margin:2.0pt 0in 2.0pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.2%;">
<p style="margin:2.0pt 0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(3)</font></p>    </td>
<td width="82%" valign="top" style="padding:0in 0in 0in 0in;width:82.44%;">    <div style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;">
<p style="border:none;margin:2.0pt 0in;padding:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Filing Party: <br> &nbsp;&nbsp;&nbsp;&nbsp; </font></p>    </div>    </td>   </tr>
<tr style="page-break-inside:avoid;">
<td width="11%" valign="top" style="padding:0in 0in 0in 0in;width:11.36%;">
<p style="margin:2.0pt 0in 2.0pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.2%;">
<p style="margin:2.0pt 0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(4)</font></p>    </td>
<td width="82%" valign="top" style="padding:0in 0in 0in 0in;width:82.44%;">    <div style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;">
<p style="border:none;margin:2.0pt 0in;padding:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Date Filed: <br><br></font></p>    </div>    </td>   </tr>  </table>
</div>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\jms\109431\20-5765-7\task9711640\5765-7-ba.htm',USER='109431',CD='May 14 07:46 2020' -->

<div style="page-break-before:always;"></div>
<div>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman"><img width="111" height="75" src="g57657bai001.jpg"></font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Arial" style="font-size:10.0pt;">Incyte Corporation</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Arial" style="font-size:10.0pt;">1801 Augustine Cut-Off</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Arial" style="font-size:10.0pt;">Wilmington, Delaware 19803</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="border:none;border-bottom:solid #005CAC 1.5pt;padding:0in 0in 5.0pt 0in;">
<p style="border:none;margin:0in 0in .0001pt;padding:0in;"><font size="5" color="#005cac" face="Arial" style="color:#005CAC;font-size:18.0pt;">Supplement to Proxy Statement<br> for Annual Meeting of Stockholders</font></p>
</div>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Arial" style="font-size:10.0pt;font-weight:bold;">Tuesday, May 26, 2020</font></b></p>
<p style="margin:0in 0in .0001pt;"><b><font size="1" face="Arial" style="font-size:9.0pt;font-weight:bold;">1:00 PM Eastern Daylight Time</font></b></p>
<p style="margin:0in 0in .0001pt;"><b><font size="1" face="Arial" style="font-size:9.0pt;font-weight:bold;">1815 Augustine Cut-Off, Wilmington, Delaware 19803</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Arial" style="font-size:10.0pt;">This supplement, dated May 14, 2020, supplements the definitive proxy statement (the &#147;Proxy Statement&#148;) of Incyte Corporation (the &#147;Company&#148; or &#147;Incyte&#148;) filed with the Securities and Exchange Commission on April 24, 2020, relating to the Company&#146;s Annual Meeting of Stockholders to be held on May 26, 2020 (the &#147;2020 Annual Meeting&#148;).</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" color="#005cac" face="Arial" style="color:#005CAC;font-size:11.0pt;">Corporate Governance Update</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" color="#31abe2" face="Arial" style="color:#31ABE2;font-size:10.0pt;font-weight:bold;">Departing Director</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Arial" style="font-size:10.0pt;">On May 13, 2020, Paul A. Friedman, M.D. notified the Company that, should he be re-elected as a member of the Company&#146;s Board of Directors (the &#147;Board&#148;), at the Company&#146;s 2020 Annual Meeting, he will serve on the Board until the Company&#146;s 2021 Annual Meeting of Stockholders (the &#147;2021 Annual Meeting&#148;) and will retire from the Board effective at the time of the Company&#146;s 2021 Annual Meeting of Stockholders. Dr. Friedman has been a member of our Board since 2001.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" color="#31abe2" face="Arial" style="color:#31ABE2;font-size:10.0pt;font-weight:bold;">Changes to Nominating and Corporate Governance Composition</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Arial" style="font-size:10.0pt;">Effective May 13, 2020, Dr. Friedman has resigned from the Nominating and Corporate Governance Committee. Our Board has added Jean-Jacques Bienaim&#233; to the Nominating and Corporate Governance Committee.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" color="#31abe2" face="Arial" style="color:#31ABE2;font-size:10.0pt;font-weight:bold;">New Science and Technology Committee of the Board of Directors</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Arial" style="font-size:10.0pt;">Our Board has created a new Science and Technology Committee (the &#147;Science Committee&#148;).&#160; Our Board has appointed Dr. Friedman as Chair of this Science Committee because of Dr. Friedman&#146;s extensive expertise in drug development and discovery, including medicinal chemistry and biology, as well as his deep understanding of Incyte and our research and development organization.&#160; Accordingly, our Board believes that, even with this limited time on the Science Committee, Dr. Friedman will provide the foundational expertise to assure the long term viability and value of the Science Committee.&#160; Consequently, our Board believes it is in the best interests of our stockholders that Dr. Friedman lead the new Science Committee in its oversight of our research and development operations and strategy as we seek to continue the scientific excellence at Incyte that has so far led to the discovery of four approved medicines around the world.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Arial" style="font-size:10.0pt;">Our Board has also appointed Edmund P. Harrigan, M.D. and Katherine A. High, M.D. to the Science Committee.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\jms\109431\20-5765-7\task9711640\5765-7-ba.htm',USER='109431',CD='May 14 07:46 2020' -->

</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>g57657bai001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g57657bai001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  H'!PD'!@H)" D+"PH,#QD0#PX.
M#QX6%Q(9)" F)2,@(R(H+3DP*"HV*R(C,D0R-CL]0$! )C!&2T4^2CD_0#W_
MVP!# 0L+"P\-#QT0$!T]*2,I/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]
M/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3W_P  1" !+ &\# 2(  A$! Q$!_\0
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7F^(9'&D,:QQ(J(@PJJ, "GT45!9__]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
